$3.22
+0.0600 (+1.90%)
At Close: Jun 03, 2026
CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
08:00am, Thursday, 07'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investi
CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors
04:05pm, Tuesday, 22'nd Dec 2020
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investi
CytomX Therapeutics to Present at Upcoming Investor Conferences
04:01pm, Wednesday, 11'th Nov 2020
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investi
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q3 2020 Results - Earnings Call Transcript
10:39pm, Saturday, 07'th Nov 2020
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q3 2020 Results - Earnings Call Transcript
CytomX Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
04:15pm, Thursday, 05'th Nov 2020
Company to host a conference call today, November 5, 2020, at 5:00 p.m. ET / 2:00 p.m. PT Company to host a conference call today, November 5, 2020, at 5:00 p.m. ET / 2:00 p.m. PT
CytomX Therapeutics to Announce Third Quarter 2020 Financial Results
08:00am, Thursday, 29'th Oct 2020
-Teleconference Scheduled for November 5, 2020, at 5:00 p.m. ET / 2:00 p.m. PT- -Teleconference Scheduled for November 5, 2020, at 5:00 p.m. ET / 2:00 p.m. PT-
Credit Union tops Customer Experience rankings again
07:52am, Tuesday, 20'th Oct 2020
The key role which frontline staff play in helping companies to exceed customers' expectations during Covid-19 is one of the key themes to emerge in the latest annual survey of Irish brands based on c
4 Key Customer Experience Metrics Brands Should Be Tracking
12:00am, Tuesday, 01'st Sep 2020
As we continue to deal with the pandemic, companies have to continue to deliver great customer experience. This starts by utilizing data and tools that eliminate friction and keep customers satisfied
Schneider to Test Electric Trucks as Part of Freightliner’s Customer Experience (CX) Fleet
12:00am, Wednesday, 26'th Aug 2020
Schneider has been selected to participate in the all-electric Freightliner Customer Experience (CX) Fleet.
CytomX Therapeutics (CTMX) Presents At 2020 Wedbush PacGrow Healthcare Conference - Slideshow
06:02pm, Thursday, 13'th Aug 2020
The following slide deck was published by CytomX Therapeutics, Inc. in conjunction with this event..
CytomX Therapeutics Announces Second Quarter 2020 Financial Results and Provides Business Update
08:15pm, Thursday, 06'th Aug 2020
Company to Host a Conference Call Today, August 6, 2020, at 5:30 p.m. ET / 2:30 p.m. PTSOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinic
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
CytomX Therapeutics (CTMX) Set to Announce Quarterly Earnings on Thursday
08:18am, Wednesday, 05'th Aug 2020
CytomX Therapeutics (NASDAQ:CTMX) is scheduled to announce its earnings results after the market closes on Thursday, August 6th. Analysts expect the company to announce earnings of $0.34 per share for
CytomX Therapeutics to Participate in the 2020 Wedbush PacGrow Healthcare Conference
12:00pm, Tuesday, 04'th Aug 2020
SOUTH SAN FRANCISCO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investi
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Sign In
Buy CTMX